Baricitinib
I4V-MC-KHAB
Phase 3 small_molecule active
Quick answer
Baricitinib for Covid19 Corona Virus Infection is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Covid19 Corona Virus Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active